Detalhe da pesquisa
1.
A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia.
Support Care Cancer
; 22(8): 2197-206, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24659244
2.
The role of iron supplementation during epoietin treatment for cancer-related anemia.
Med Oncol
; 26(1): 105-15, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18473194
3.
Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study.
Leukemia
; 21(4): 627-32, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17252006
4.
Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy.
J Clin Pharm Ther
; 33(4): 365-74, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18613854
5.
Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.
J Clin Oncol
; 20(10): 2486-94, 2002 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12011126
6.
Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.
J Clin Oncol
; 13(4): 989-95, 1995 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-7707128
7.
Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.
Br J Pharmacol
; 172(21): 5025-36, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26265306
8.
More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML.
Bone Marrow Transplant
; 32(12): 1119-24, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14647265
9.
Mitoxantrone and cytarabine versus daunorubicin and cytarabine in previously untreated patients with acute myeloid leukemia.
Cancer Chemother Pharmacol
; 28(6): 480-3, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1934252
10.
[Improved chances to cure hematologic diseases. The status of resources and organization of hematologic care]. / Förbättrade chanser bota blodsjukdomar. Hematologivårdens resursläge och organisation.
Lakartidningen
; 90(24): 2315-7, 1993 Jun 16.
Artigo
em Sueco
| MEDLINE | ID: mdl-8316010
11.
Mitoxantrone in the treatment of patients with non-Hodgkin's Lymphoma.
Cancer Treat Rep
; 71(12): 1209-12, 1987 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-3690531
12.
Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
Eur J Haematol
; 58(4): 233-40, 1997 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9186533
13.
Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.
Br J Haematol
; 101(2): 280-6, 1998 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-9609523
14.
Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma. Nordic Myeloma Study Group (NMSG).
Eur J Haematol
; 48(2): 70-4, 1992 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-1547878
15.
Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG)
Br J Haematol
; 77(1): 73-9, 1991 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-1998599
16.
Simultaneous presentation of relapsing non-Hodgkin's lymphoma and Hodgkin's disease.
Eur J Haematol
; 42(3): 315-6, 1989 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-2924898